Limits...
What did inspire me to write the abstract for the EPMA Congress?

View Article: PubMed Central - HTML

AUTOMATICALLY GENERATED EXCERPT
Please rate it.

Type 1 Diabetes Mellitus (DM) Male 22 years of age (Figure 1) Insulin dependent since 2003 Visual acuity: OD: 0,10 OS: Light Perception Preparing for surgical treatment Operation rejected because of: Blood hypertension (230/110 mmHg) HBA1C: 10.7 % Anemia Renal Insufficiency (not diagnosed) Hart ischemic changes, left ventricular hypertrophy (not diagnosed) DM is a major cause of avoidable blindness all over the world... Patients with diabetic retinopathy (DR) are 25 times more likely to become blind than non-diabetics... Prevalence of DR in Wisconsin Epidemiological Study of Diabetic Retinopathy was 50.1 and 54.2% in the diabetes control and complications trial in type 1 diabetes and 35-39% in United Kingdom Prospective Diabetes Study in type 2 diabetes... After 10 years of onset of DM, blindness was 1.8, 4.0 and 4.8% in type 1, insulin-treated type 2 and non-insulin-treated type 2 patients, respectively... Good glycemic control arrests the development and progression of DR, but still there are a lot of factors that can influence the DR visual loss... Technological advances have improved the diagnostic accuracy of screening methods and given an access to the diabetic patients to the specialist care... Stem cell research, especially the embryonic one, holds great promise in the search for a cure for type 1 diabetes and provide a powerful tool for controlling type 2 diabetes... The first results of the stem-cells DR- treatment were presented at the ARVO in 2011... Patients experienced improvements in the function of the optic nerve, blood flow to the eye and reduction of inflammation in the six-month period following injection and became stable for the entire follow up period... To achieve our goals of personalized treatment, we need EU support in different projects that will connect the physicians with basic science investigations and biotechnology... In the overall economic downturn tremendous budget cuts will only lead to huge burden of diabetic complications treatment.

No MeSH data available.


Related in: MedlinePlus

Fundus photography of huge retinal bleeding and retinal detachment in PDR
© Copyright Policy - open-access
Related In: Results  -  Collection

License 1 - License 2
getmorefigures.php?uid=PMC4125935&req=5

Figure 1: Fundus photography of huge retinal bleeding and retinal detachment in PDR

Mentions: Male 22 years of age (Figure 1)


What did inspire me to write the abstract for the EPMA Congress?
Fundus photography of huge retinal bleeding and retinal detachment in PDR
© Copyright Policy - open-access
Related In: Results  -  Collection

License 1 - License 2
Show All Figures
getmorefigures.php?uid=PMC4125935&req=5

Figure 1: Fundus photography of huge retinal bleeding and retinal detachment in PDR
Mentions: Male 22 years of age (Figure 1)

View Article: PubMed Central - HTML

AUTOMATICALLY GENERATED EXCERPT
Please rate it.

Type 1 Diabetes Mellitus (DM) Male 22 years of age (Figure 1) Insulin dependent since 2003 Visual acuity: OD: 0,10 OS: Light Perception Preparing for surgical treatment Operation rejected because of: Blood hypertension (230/110 mmHg) HBA1C: 10.7 % Anemia Renal Insufficiency (not diagnosed) Hart ischemic changes, left ventricular hypertrophy (not diagnosed) DM is a major cause of avoidable blindness all over the world... Patients with diabetic retinopathy (DR) are 25 times more likely to become blind than non-diabetics... Prevalence of DR in Wisconsin Epidemiological Study of Diabetic Retinopathy was 50.1 and 54.2% in the diabetes control and complications trial in type 1 diabetes and 35-39% in United Kingdom Prospective Diabetes Study in type 2 diabetes... After 10 years of onset of DM, blindness was 1.8, 4.0 and 4.8% in type 1, insulin-treated type 2 and non-insulin-treated type 2 patients, respectively... Good glycemic control arrests the development and progression of DR, but still there are a lot of factors that can influence the DR visual loss... Technological advances have improved the diagnostic accuracy of screening methods and given an access to the diabetic patients to the specialist care... Stem cell research, especially the embryonic one, holds great promise in the search for a cure for type 1 diabetes and provide a powerful tool for controlling type 2 diabetes... The first results of the stem-cells DR- treatment were presented at the ARVO in 2011... Patients experienced improvements in the function of the optic nerve, blood flow to the eye and reduction of inflammation in the six-month period following injection and became stable for the entire follow up period... To achieve our goals of personalized treatment, we need EU support in different projects that will connect the physicians with basic science investigations and biotechnology... In the overall economic downturn tremendous budget cuts will only lead to huge burden of diabetic complications treatment.

No MeSH data available.


Related in: MedlinePlus